The authors present the case for recycling urine to recover nutrients for use as fertilizers. This practice would positively impact the environment by decreasing man-made nitrogen compounds and water usage.
The results suggest that PM2.5 is an independent risk factor for kidney failure in patients with IgAN.
Implementation Strategies for High-impact Nephrology Trials
The authors discuss the apparent lack of implementation – integrating new practices within a setting, and de-implementation – removing low-value, wasteful or harmful treatments from practice, following kidney trials.
To address this deficit, they examine two frameworks that present promising avenues of inquiry for kidney researchers and urge increased evidence uptake after trial publication to benefit the global kidney care community.
Caring for Australians and New Zealanders With Kidney Impairment Guidelines: Rapid Development of Urate-Lowering Therapy Guidelines for People With Chronic Kidney Disease
The Caring for Australians and New Zealanders with Kidney Impairment (CARI) is an evidence-based guideline on urate-lowering therapy in patients with chronic kidney disease (CKD) rapidly produced in response to new clinical trial publications on the topic by the Australian Kidney Trials Network.
The result is a strong recommendation against using urate-lowering therapies in those with CKD (not receiving dialysis) and asymptomatic hyperuricemia.